agilon health, inc. (NYSE:AGL) Shares Acquired by AQR Capital Management LLC

AQR Capital Management LLC boosted its position in shares of agilon health, inc. (NYSE:AGL - Free Report) by 3,338.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,356,438 shares of the company's stock after buying an additional 1,316,990 shares during the period. AQR Capital Management LLC owned approximately 0.33% of agilon health worth $8,871,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Capital International Investors raised its holdings in shares of agilon health by 84.7% in the first quarter. Capital International Investors now owns 20,197,932 shares of the company's stock worth $123,207,000 after buying an additional 9,263,296 shares during the period. Capital World Investors boosted its position in agilon health by 7.4% during the 4th quarter. Capital World Investors now owns 55,218,496 shares of the company's stock valued at $692,992,000 after acquiring an additional 3,813,214 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in agilon health by 46.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company's stock valued at $127,256,000 after acquiring an additional 3,195,087 shares in the last quarter. Wellington Management Group LLP boosted its position in agilon health by 2.9% during the 4th quarter. Wellington Management Group LLP now owns 42,510,030 shares of the company's stock valued at $533,501,000 after acquiring an additional 1,191,253 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC bought a new stake in agilon health during the 1st quarter valued at $2,975,000.

Insider Activity at agilon health

In other agilon health news, CEO Steven Sell purchased 20,000 shares of the business's stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.20% of the stock is owned by company insiders.

agilon health Price Performance

Shares of agilon health stock traded down $0.42 on Thursday, hitting $3.16. The company's stock had a trading volume of 3,886,751 shares, compared to its average volume of 5,018,192. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36. agilon health, inc. has a 1 year low of $3.04 and a 1 year high of $20.37. The firm has a fifty day moving average price of $4.64 and a 200-day moving average price of $5.41. The company has a market capitalization of $1.30 billion, a price-to-earnings ratio of -4.79 and a beta of 0.54.

agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, meeting the consensus estimate of ($0.07). agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The firm had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the business earned ($0.04) EPS. agilon health's revenue for the quarter was up 38.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that agilon health, inc. will post -0.32 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

AGL has been the topic of several recent research reports. Evercore ISI increased their target price on agilon health from $5.50 to $7.00 and gave the company an "in-line" rating in a research report on Tuesday, July 9th. Benchmark reaffirmed a "buy" rating and set a $9.00 target price on shares of agilon health in a research report on Thursday, August 8th. Bank of America cut agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price objective for the company. in a research report on Wednesday. Deutsche Bank Aktiengesellschaft lowered their price objective on agilon health from $5.00 to $4.00 and set a "hold" rating for the company in a research report on Friday, August 9th. Finally, Royal Bank of Canada reissued an "outperform" rating and issued a $8.00 price objective on shares of agilon health in a research report on Wednesday, August 7th. Two equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $8.22.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.